Niki BioSolutions, Inc. (NIKI) Operating Expenses (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Operating Expenses came in at $2.3 million in Q4 2025, up 638.98% YoY from $316690.0 in Q4 2024, and up 283.7% on a QoQ basis from -$1.3 million in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Operating Expenses (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 6 years of Operating Expenses data on file, last reported at $2.3 million in Q4 2025.
- Quarterly Operating Expenses rose 638.98% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $1.4 million (up 104.71% YoY) and the FY2025 annual result came in at -$1.8 million, up 53.88% from the prior year.
- Operating Expenses improved to $2.3 million in Q4 2025, from -$1.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $2.3 million in Q4 2025 to a low of -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 2.34 Mn |
| Aug 31, 2025 | -1.27 Mn |
| Nov 30, 2024 | 316,690.00 |
| Aug 31, 2024 | 358,922.00 |
| Jun 30, 2020 | 307,270.00 |
| Dec 31, 2019 | 554,791.00 |
| Dec 31, 2018 | 398,899.00 |
| Dec 31, 2017 | 5.69 Mn |